ProJenX and Unlearn partnered to implement genAI technology for a Phase I trial of prosetin for amyotrophic lateral sclerosis ...

The partnership will employ the ALS-Digital Twin Generator of Unlearn to enhance the trial's evaluation process.

Mabylon has received grants from Target ALS and the ALS Association to develop human-derived antibodies to help restore ...

Scientists at UC Davis in Northern California have made a major breakthrough that could have a significant positive impact on ...

La Esperanza plans to open a new location in the Ivy at Berlin Place in the next few months amidst rapid growth on the south ...

The Speech Accessibility Project is a research initiative to make voice recognition technology more useful for people with a range of diverse speech patterns and disabilities. The project is housed ...

On successful completion of preclinical testing of the CAR-Treg, PolTREG expects to initiate, as early as next year, the first-in-human trial of the engineered candidate to treat MS and amyotrophic ...

Researchers with McMaster University have discovered that the protein mutated in patients with Huntington disease doesn't ...

Researchers with McMaster University have discovered that the protein mutated in patients with Huntington's Disease doesn't repair DNA as intended ...

A new study shows that automatic speech recognition (ASR) systems trained on speech from people with Parkinson’s disease are ...

Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the “Company”), a clinical-stage biotechnology company developing ...

A pioneer in the field of viral oncogenesis, Branton spearheaded the creation of the Canadian Cancer Research Alliance, a ...